MedTrace Logo

Gilead Sustained Virologic Response (SVR) Registry

NCT01457755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6625

Last updated 2018-08-31

No results posted yet for this study

Summary

This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.

Conditions

  • Hepatitis C, Chronic

Sponsors & Collaborators

Principal Investigators

  • Gilead Study Director · Gilead Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-13
Primary Completion
2017-03-28
Completion
2018-01-08

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Canada
  • Czechia
  • Estonia
  • France
  • Germany
  • Italy
  • Netherlands
  • New Zealand
  • Poland
  • Puerto Rico
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457755 on ClinicalTrials.gov